October 17, 2024
Newsroom
Displaying 51–60 of 136
August 22, 2024
Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 14, 2024
Seer Appoints Nicolas Roelofs to its Board of Directors
August 9, 2024
Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference
August 8, 2024
Seer Reports Second Quarter 2024 Financial Results
July 18, 2024
Seer to Report Second Quarter 2024 Financial Results on August 8, 2024
June 11, 2024
Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery
June 2, 2024
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
May 8, 2024
Seer Reports First Quarter 2024 Financial Results
May 8, 2024
Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions
No results found.
Starting your proteomics research is effortless
Connect with an expert to discuss which path to the full proteome is right for you.
-
Bring the Proteograph Product Suite in-house
-
Run a project with
Seer Technology
Access Center -
Conduct a project with
a Seer service provider
or Center of Excellence